A Study Evaluating the Hair Regrowth Efficacy and Safety of ALRV5XR in Female Subjects With Hair Loss
NCT04450602 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 46
Last updated 2020-06-30
Summary
To demonstrate that the ALRV5XR multi-molecular targeting treatment regimen of a daily shampoo, conditioner, topical serum and oral supplement is superior to placebo in promoting hair growth as assessed by change in hair density and percentage of terminal hair regrowth after ALRV5XR therapy.
This will be a single-centre, double-blind, randomized, placebo-controlled study in female subjects randomized to a 1:1 ratio of test article to placebo.
Subjects will be asked to use the study products on a daily basis for the duration of the 24-week study. Subjects will take one capsule twice daily (one in the morning and one in the evening) and will be asked to use 3-7mL of the shampoo, 3-7mL of the conditioner, and 1mL of the topical nutriment daily. Subjects will receive detailed instructions regarding the order and duration of application of each product.
Subjects in the active arm will receive active capsules, shampoo, conditioner and topical nutriment. Subjects on placebo will receive placebo capsules, shampoo, conditioner and topical nutriment. All subjects will be instructed to take the capsules orally, one in the morning and one in the evening, prior to consuming food. Shampoo and conditioner are to be used once per day when washing the hair and nutriment applied at the end of the day prior to bedtime. To facilitate this, subjects will receive a 3-month supply of each product (supplement, shampoo, conditioner, and scalp nutriment). Subjects will continue the daily regimen for 24 weeks, visiting the clinic at week 12 for an interim assessment.
Conditions
- Androgenetic Alopecia
- Androgenic Alopecia
- Telogen Effluvium
- Thinning Hair
- Hair Loss/Baldness
- Hair Thinning
Interventions
- DIETARY_SUPPLEMENT
-
ALRV5XR
ALRV5XR oral supplement. Dose/Route/Schedule: 1 capsule/oral twice daily. Take one capsule in the morning and one capsule in the evening. Take 30-60 minutes before food. If stomach upset occurs, subjects will be instructed to take the capsule at the beginning of a meal. There should be no deviation from the daily nutriment regimen (although in the event a capsule or day is missed, subject should continue with regimen the following day.)
- OTHER
-
ALRV5XR Shampoo
ALRV5XR Shampoo. Dose/Route/Schedule: 3-7 ml, topical, daily. The amount of shampoo used will vary by subject, based on length of hair. Short hair will use approximately 3ml of shampoo per wash and long hair as much as 7 ml. For short hair, an amount equivalent to a quarter in the palm of a hand, and for long hair a half-dollar size. There should be no deviation from the daily nutriment regimen (although in the event a day is missed, subject should continue with regimen the following day
- OTHER
-
ALRV5XR Conditioner
ALRV5XR Conditioner. Dose/Route/Schedule: 3-7 ml, topical, daily. The amount of conditioner used will vary by subject based on length of hair. Short hair will use approximately 3ml of conditioner per wash and long hair as much as 7 ml. For short hair, an amount equivalent to a quarter in the palm of a hand, and for long hair a half-dollar size. There should be no deviation from the daily nutriment regimen (although in the event a day is missed, subject should continue with regimen the following day
- OTHER
-
ALRV5XR Hair Follicle Serum (Nutriment)
ALRV5XR topical Hair Follicle serum (Nutriment), sealed in an airless pump dispensing bottle, metered at 0.2ml per depression. Dose/Route/Schedule: 1ml, topical, daily, applied at night. Topical serum (referred to as the Nutriment) dosage is metered as 5 x depressions of plunger per day to cover areas of thinning scalp and adjacent scalp areas. Care should be taken to limit the Nutriment in hair. Each depression is metered at 0.2ml for a daily dose of 1.0 ml. Each container has 30ml of Nutriment. Nutriment will dry within a few minutes and any on the hair will also dry. The dried effect in the hair should not cause oiliness or dryness on scalp or hair. There should be no deviation from the daily nutriment regimen (although in the event a day is missed, subject should continue with regimen the following day.)
- DIETARY_SUPPLEMENT
-
Placebo
Placebo oral supplement. Dose/Route/Schedule: 1 capsule/oral twice daily. Take one capsule in the morning and one capsule in the evening. Take 30-60 minutes before food. If stomach upset occurs, subjects will be instructed to take the capsule at the beginning of a meal. There should be no deviation from the daily nutriment regimen (although in the event a capsule or day is missed, subject should continue with regimen the following day.)
- OTHER
-
Placebo Shampoo
Placebo Shampoo. Dose/Route/Schedule: 3-7 ml, topical, daily. The amount of shampoo used will vary by subject, based on length of hair. Short hair will use approximately 3ml of shampoo per wash and long hair as much as 7 ml. For short hair, an amount equivalent to a quarter in the palm of a hand, and for long hair a half-dollar size. There should be no deviation from the daily nutriment regimen (although in the event a day is missed, subject should continue with regimen the following day
- OTHER
-
Placebo Conditioner
Placebo Conditioner. Dose/Route/Schedule: 3-7 ml, topical, daily. The amount of conditioner used will vary by subject based on length of hair. Short hair will use approximately 3ml of conditioner per wash and long hair as much as 7 ml. For short hair, an amount equivalent to a quarter in the palm of a hand, and for long hair a half-dollar size. There should be no deviation from the daily nutriment regimen (although in the event a day is missed, subject should continue with regimen the following day
- OTHER
-
Placebo Hair Follicle Serum (Nutriment)
Placebo topical Hair Follicle serum (Nutriment), sealed in an airless pump dispensing bottle, metered at 0.2ml per depression. Dose/Route/Schedule: 1ml, topical, daily, applied at night. Topical serum (referred to as the Nutriment) dosage is metered as 5 x depressions of plunger per day to cover areas of thinning scalp and adjacent scalp areas. Care should be taken to limit the Nutriment in hair. Each depression is metered at 0.2ml for a daily dose of 1.0 ml. Each container has 30ml of Nutriment. Nutriment will dry within a few minutes and any on the hair will also dry. The dried effect in the hair should not cause oiliness or dryness on scalp or hair. There should be no deviation from the daily nutriment regimen (although in the event a day is missed, subject should continue with regimen the following day.)
Sponsors & Collaborators
-
Arbor Life Labs
lead INDUSTRY
Principal Investigators
-
Luciano Marra (Medical Director), PhD · Arbor Life Labs
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-04-03
- Primary Completion
- 2018-10-20
- Completion
- 2018-10-23
Countries
- United States
Study Locations
More Related Trials
-
PF-06651600 for the Treatment of Alopecia Areata
NCT03732807 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy of Platelet-Rich Plasma Versus Mesotherapy in Androgenetic Alopecia: A Retrospective Study
NCT05129800 ·Status: COMPLETED
-
A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of ALD-102 Solution in Subjects With Alopecia Areata
NCT06826196 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Safety and Efficacy Study of Bimatoprost in the Treatment of Women With Female Pattern Hair Loss
NCT01325350 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Platelet Rich Plasma in Androgenetic Alopecia
NCT02074943 ·Status: UNKNOWN ·Phase: NA
-
Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Subjects With Alopecia Areata
NCT02974868 ·Status: COMPLETED ·Phase: PHASE2
-
Microarray Analysis of Scalp Biopsies After Minoxidil Treatment
NCT01309191 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy Study of Bimatoprost in the Treatment of Men With Androgenic Alopecia
NCT01325337 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness and Safety of Platelet-rich Plasma and Topical 5% Minoxidil Combination in Male Androgenetic Alopecia
NCT06043349 ·Status: UNKNOWN ·Phase: PHASE4
-
Clinical Trial in Females for Female Pattern Hair Loss
NCT01226459 ·Status: COMPLETED ·Phase: PHASE3
-
Minoxidil Response Testing in Females With Female Pattern Hair Loss
NCT02206802 ·Status: COMPLETED
-
Efficacy of the New Viviscal Professional Strength Oral Supplement in Females With Thinning Hair
NCT02302053 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate the Efficacy and Safety of CTP-543 in Adults With Moderate to Severe Alopecia Areata (THRIVE-AA1)
NCT04518995 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluate the Efficacy and Safety of SHR0302 in Adult Patients With Severe Alopecia Areata
NCT05470413 ·Status: UNKNOWN ·Phase: PHASE3
-
Clinical Trial in Females With Female Pattern Hair Loss
NCT01145625 ·Status: COMPLETED ·Phase: PHASE3
-
The Efficiency Of The Methotrexate At Patients Affected By Grave Pelade
NCT02037191 ·Status: COMPLETED ·Phase: PHASE3
-
Viviscal Extra-Strength Formulation To Promote Hair Growth And Decrease Shedding In Women With Thinning Hair
NCT02297360 ·Status: COMPLETED ·Phase: NA
-
Phase I Study of Safety and Pharmacokinetics of Topical Solution in Subjects With Androgenetic Alopecia
NCT05864885 ·Status: UNKNOWN ·Phase: PHASE1
-
Safety and Efficacy of Oral NXC-736 in Adult Participants With Moderate and Severe Alopecia Areata
NCT06104839 ·Status: RECRUITING ·Phase: PHASE2
-
Safety and Tolerability of Hair Stimulating Complex (HSC) in Female Pattern Hair Loss
NCT03662854 ·Status: UNKNOWN ·Phase: PHASE1
-
Laser Assisted Delivery of Minoxidil in Androgenetic Alopecia
NCT03852992 ·Status: WITHDRAWN ·Phase: PHASE2
-
Safety and Efficacy of VDPHL01 in Females With Androgenetic Alopecia (AGA)
NCT07146022 ·Status: RECRUITING ·Phase: PHASE3
-
Effect of PRP on the Therapy for Hair Growth
NCT02087319 ·Status: COMPLETED ·Phase: NA
-
Topical Crisaborole in Patients with Alopecia Areata
NCT04299503 ·Status: WITHDRAWN ·Phase: PHASE2
-
Study Evaluating the Efficacy and Safety of BENEV Exosome Regenerative Complex+ for Self-perceived Thinning Hair
NCT06571799 ·Status: COMPLETED ·Phase: NA